NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+130.3%
5Y CAGR+31.8%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+130.3%/yr
Annual compound
5Y CAGR
+31.8%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.87 | +83.4% |
| 2024 | 3.20 | +0.6% |
| 2023 | 3.18 | +562.0% |
| 2022 | 0.48 | -84.3% |
| 2021 | 3.06 | +106.8% |
| 2020 | 1.48 | - |